Aptose to Present at the RBC Capital Markets 2015 Global Healthcare Conference
News Feb 20, 2015
Aptose Biosciences Inc. has announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, will present at the upcoming RBC Capital Markets 2015 Global Healthcare Conference on Tuesday, February 24th at 1:35 p.m. ET at the Kennedy 1 Room at the New York Palace Hotel in New York City.
Dr. Rice will provide a corporate overview of the Company's recent activities and strategic direction including plans to develop Aptose's lead clinical agent, APTO-253 for acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and other hematologic malignancies.
A live audio webcast of the Aptose presentation will be accessible by visiting: http://www.veracast.com/webcasts/rbc/healthcare2015/84110376508.cfm.
Detecting Heart Damage Long Before Parkinson's Symptoms AppearNews
Mapping inflammation in the heart before diagnosis of Parkinson's disease: a new tool for tracking treatment efficacyREAD MORE
3D Super-Resolution Nanoscopes Used To Identify Amyloid PlaquesNews
A new development in 3D super-resolution imaging gives insight on Alzheimer's diseaseREAD MORE